Infliximab Ulcerative Colitis Related articles:*Acute severe colitis*Mild-to-Moderate Ulcerative Colitis*Probiotics in Ulcerative Colitis*Methotrexate in Ulcerative Colitis*Infliximab with Azathiopurine (Ulcerative Colitis)*Acute severe colitis: Accelerated induction Infliximab*Adalimumab in Ulcerative Colitis (ULTRA studies)*Golimumab in Ulcerative Colitis*Vedolizumab vs Adalimumab Ulcerative Colitis*Vedolizumab Ulcerative Colitis*Tofacitinib (OCTAVE Ulcerative Colitis)*Ustekinumab (Ulcerative colitis)*Acute severe colitis: Infliximab vs ciclosporin (CONTRUCT) Infliximab for Induction and Maintenance Therapy ..
Tag : Ulcerative colitis
Several diagnostic and treatment algorithms for pouchitis Pouchitis disease activity index: Pouchitis diagnostic algorithm Shen 2013 Clin Gastroenterol Hepatol. Pouchitis treatment algorithm. Shen 2013 Clin Gastroenterol Hepatol. Alternative treatment algorithm (reference?) Segal et al. Systematic Review With Meta-Analysis: The Management of Chronic Refractory Pouchitis With an Evidence-Based Treatment Algorithm. Aliment Pharmacol Ther Actions 2017 Nguyen ..
Mild-to-moderate Ulcerative Colitis induction therapy: budesonide (CORE studies) Once-daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study William J Sandborn, Simon Travis, Luigi Moro , Richard Jones, Theres Gautille, Robert Bagin , Michael Huang, Phil Yeung, E David Ballard Background & aims: Budesonide is a corticosteroid with minimal systemic corticosteroid activity ..
Thiopurine metabolite metabolism, screening, monitoring and side effect management. References: Lauren Beswick, Antony B Friedman & Miles P Sparrow (2014) The role ofthiopurine metabolite monitoring in inflammatory bowel disease, Expert Review of Gastroenterology & Hepatology, 8:4, 383-392, DOI: 10.1586/17474124.2014.894878 Warner B, Johnston E, Arenas-Hernandez M, et al. Frontline Gastroenterology Published Online First. doi:10.1136/flgastro-2..
The release location of aminosalicylate preparations for the treatment of ulcerative colitis. References: Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet. 2012;380(9853):1606-1619. doi:10.1016/S0140-6736(..
Infliximab with Azathiopurine in Ulcerative Colitis Related articles:*Acute severe colitis*Mild-to-Moderate Ulcerative Colitis*Probiotics in Ulcerative Colitis*Methotrexate in Ulcerative Colitis*Infliximab Ulcerative Colitis*Acute severe colitis: Accelerated induction Infliximab*Adalimumab in Ulcerative Colitis (ULTRA studies)*Golimumab in Ulcerative Colitis*Vedolizumab vs Adalimumab Ulcerative Colitis*Vedolizumab Ulcerative Colitis*Tofacitinib (OCTAVE Ulcerative Colitis)*Ustekinumab (Ulcerative colitis)*Acute severe colitis: Infliximab vs ciclosporin (CONTRUCT) Infliximab Azathiopurine combination therapy in ..
Related articles:*Acute severe colitis*Mild-to-Moderate Ulcerative Colitis*Probiotics in Ulcerative Colitis*Methotrexate in Ulcerative Colitis*Infliximab Ulcerative Colitis*Infliximab with Azathiopurine (Ulcerative Colitis)*Acute severe colitis: Accelerated induction Infliximab*Golimumab in Ulcerative Colitis*Vedolizumab vs Adalimumab Ulcerative Colitis*Vedolizumab Ulcerative Colitis*Tofacitinib (OCTAVE Ulcerative Colitis)*Ustekinumab (Ulcerative colitis)*Acute severe colitis: Infliximab vs ciclosporin (CONTRUCT) Adalimumab for induction of clinical remission in moderately to severely active ulcerative ..
Related articles:*Acute severe colitis*Mild-to-Moderate Ulcerative Colitis*Probiotics in Ulcerative Colitis*Infliximab Ulcerative Colitis*Infliximab with Azathiopurine (Ulcerative Colitis)*Acute severe colitis: Accelerated induction Infliximab*Adalimumab in Ulcerative Colitis (ULTRA studies)*Golimumab in Ulcerative Colitis*Vedolizumab vs Adalimumab Ulcerative Colitis*Vedolizumab Ulcerative Colitis*Tofacitinib (OCTAVE Ulcerative Colitis)*Ustekinumab (Ulcerative colitis)*Acute severe colitis: Infliximab vs ciclosporin (CONTRUCT) Meta-analysis MTX (methotrexate) vs placebo in maintenance ulcerative colitis. The ..
Related articles:*Acute severe colitis*Mild-to-Moderate Ulcerative Colitis*Probiotics in Ulcerative Colitis*Methotrexate in Ulcerative Colitis*Infliximab Ulcerative Colitis*Infliximab with Azathiopurine (Ulcerative Colitis)*Acute severe colitis: Accelerated induction Infliximab*Adalimumab in Ulcerative Colitis (ULTRA studies)*Golimumab in Ulcerative Colitis*Vedolizumab vs Adalimumab Ulcerative Colitis*Vedolizumab Ulcerative Colitis*Ustekinumab (Ulcerative colitis)*Acute severe colitis: Infliximab vs ciclosporin (CONTRUCT) Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis (2017) ..
Related articles:*Acute severe colitis*Mild-to-Moderate Ulcerative Colitis*Probiotics in Ulcerative Colitis*Methotrexate in Ulcerative Colitis*Infliximab Ulcerative Colitis*Infliximab with Azathiopurine (Ulcerative Colitis)*Acute severe colitis: Accelerated induction Infliximab*Adalimumab in Ulcerative Colitis (ULTRA studies)*Vedolizumab vs Adalimumab Ulcerative Colitis*Vedolizumab Ulcerative Colitis*Tofacitinib (OCTAVE Ulcerative Colitis)*Ustekinumab (Ulcerative colitis)*Acute severe colitis: Infliximab vs ciclosporin (CONTRUCT) Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With ..
Related articles:*Acute severe colitis*Mild-to-Moderate Ulcerative Colitis*Methotrexate in Ulcerative Colitis*Infliximab Ulcerative Colitis*Infliximab with Azathiopurine (Ulcerative Colitis)*Acute severe colitis: Accelerated induction Infliximab*Adalimumab in Ulcerative Colitis (ULTRA studies)*Golimumab in Ulcerative Colitis*Vedolizumab vs Adalimumab Ulcerative Colitis*Vedolizumab Ulcerative Colitis*Tofacitinib (OCTAVE Ulcerative Colitis)*Ustekinumab (Ulcerative colitis)*Acute severe colitis: Infliximab vs ciclosporin (CONTRUCT) Cochrane analysis comparing probiotics and mesalazine as maintenance treatment in ..
BOUGUEN, G., ROBLIN, X., BOURREILLE, A., FEIER, L., FILIPPI, J., NANCEY, S., … PEYRIN-BIROULET, L. (2010). Infliximab for refractory ulcerative proctitis. Alimentary Pharmacology & Therapeutics, 31(11), 1178–1185. doi:10.1111/j.1365-2036.2010.04293.x BACKGROUND: Efficacy of infliximab in treating ulcerative proctitis remains unknown. AIM: To evaluate the clinical, biological and endoscopic efficacy of infliximab therapy in refractory proctitis. METHODS: The ..
Mallet, A.-L., Bouguen, G., Conroy, G., Roblin, X., Delobel, J.-B., Bretagne, J.-F., … Peyrin-Biroulet, L. (2017). Azathioprine for refractory ulcerative proctitis: A retrospective multicenter study. Digestive and Liver Disease, 49(3), 280–285. doi:10.1016/j.dld.2016.12.001 BACKGROUND: Efficacy of azathioprine (AZA) in refractory ulcerative proctitis (UP) is unknown. METHODS: All patients treated with AZA for refractory UP in three ..
Lawrance, I. C., Baird, A., Lightower, D., Radford-Smith, G., Andrews, J. M., & Connor, S. (2017). Efficacy of Rectal Tacrolimus for Induction Therapy in Patients With Resistant Ulcerative Proctitis. Clinical Gastroenterology and Hepatology, 15(8), 1248–1255. doi:10.1016/j.cgh.2017.02.027 BACKGROUND & AIMS: Resistant ulcerative proctitis can be extremely difficult to manage. Topically administered tacrolimus, however, may be effective ..
Related articles:*Acute severe colitis*Mild-to-Moderate Ulcerative Colitis*Probiotics in Ulcerative Colitis*Methotrexate in Ulcerative Colitis*Infliximab Ulcerative Colitis*Infliximab with Azathiopurine (Ulcerative Colitis)*Acute severe colitis: Accelerated induction Infliximab*Adalimumab in Ulcerative Colitis (ULTRA studies)*Golimumab in Ulcerative Colitis*Vedolizumab vs Adalimumab Ulcerative Colitis*Vedolizumab Ulcerative Colitis*Tofacitinib (OCTAVE Ulcerative Colitis)*Acute severe colitis: Infliximab vs ciclosporin (CONTRUCT) Sands BE, Sandborn WJ, Panaccione R, et al. Ustekinumab ..
Related articles:*Acute severe colitis*Mild-to-Moderate Ulcerative Colitis*Probiotics in Ulcerative Colitis*Methotrexate in Ulcerative Colitis*Infliximab Ulcerative Colitis*Infliximab with Azathiopurine (Ulcerative Colitis)*Acute severe colitis: Accelerated induction Infliximab*Adalimumab in Ulcerative Colitis (ULTRA studies)*Golimumab in Ulcerative Colitis*Vedolizumab vs Adalimumab Ulcerative Colitis*Vedolizumab Ulcerative Colitis*Tofacitinib (OCTAVE Ulcerative Colitis)*Ustekinumab (Ulcerative colitis) Williams JG, Alam MF, Alrubaiy L, et al. Infliximab versus ciclosporin for steroid-resistant ..
Related articles:*Acute severe colitis*Mild-to-Moderate Ulcerative Colitis*Probiotics in Ulcerative Colitis*Methotrexate in Ulcerative Colitis*Infliximab Ulcerative Colitis*Infliximab with Azathiopurine (Ulcerative Colitis)*Adalimumab in Ulcerative Colitis (ULTRA studies)*Golimumab in Ulcerative Colitis*Vedolizumab vs Adalimumab Ulcerative Colitis*Vedolizumab Ulcerative Colitis*Tofacitinib (OCTAVE Ulcerative Colitis)*Ustekinumab (Ulcerative colitis)*Acute severe colitis: Infliximab vs ciclosporin (CONTRUCT) Gibson, D. J., Heetun, Z. S., Redmond, C. E., Nanda, K. S., ..
Mild-to-Moderate Ulcerative Colitis – AGA guideline Related articles:*Acute severe colitis*Probiotics in Ulcerative Colitis*Methotrexate in Ulcerative Colitis*Infliximab Ulcerative Colitis*Infliximab with Azathiopurine (Ulcerative Colitis)*Acute severe colitis: Accelerated induction Infliximab*Adalimumab in Ulcerative Colitis (ULTRA studies)*Golimumab in Ulcerative Colitis*Vedolizumab vs Adalimumab Ulcerative Colitis*Vedolizumab Ulcerative Colitis*Tofacitinib (OCTAVE Ulcerative Colitis)*Ustekinumab (Ulcerative colitis)*Acute severe colitis: Infliximab vs ciclosporin ..
Recent Comments